Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Terranueva Corp C.TEQ

Terranueva Corporation is a Canada-based cannabis company. The Company, through its subsidiary, Terranueva Pharma Corporation, holds the necessary licenses from Health Canada. It is focused on providing the Canadian and international markets with first-rate medicinal and recreational cannabis. The Company seeks to develop cannabis that meets the primary motivations of consumers: chronic pain, migraines, sleep disorders and anxiety. Its products may be distributed in clinic, pharmacy, dispensaries, its Website and direct sale. The Company's Certification, Research and Development Unit (CRDU) is located in L'Assomption, Quebec, Canada. Its production approach is developed according to modular production principles. Its crops are cultivated in a computer-assisted, automated and controlled environment at all times.


CSE:TEQ - Post by User

Bullboard Posts
Post by Wino999on Dec 11, 2019 9:46am
83 Views
Post# 30443288

December 11 NEWS RELEASE

December 11 NEWS RELEASE
Terranueva Obtains a $2 Million Revolving Credit and Updates MONTREAL, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Corporation Terranueva (CSE: TEQ) ("Terranueva" or the "Company") announces the closing of a secured $2M revolving credit facility (the "Revolving Credit") with a lending institution. Under the terms of the Revolving Credit, the funds will be used to finance the activities of its subsidiary, Terranueva Pharma Corporation, to finance its cannabis processing operations and, if necessary, to guarantee its working capital. The Revolving Credit is granted for a minimum one-year term and will bear interest at an annual rate of 9.95% when the Revolving Credit is used. "This funding represents an important milestone for Terranueva. With the available funds, Terranueva is ensuring that it continues its production activities to deliver quality products from automated cleanrooms in our CRDU," said Francisco Junior Perez, Terranueva's Chief Operating Officer. Crops and Health Canada The Company has harvested several crops that meet positively Health Canada standards at its research centre since the summer of 2019, and its crops have received very satisfactory results following analyses by an independent laboratory. Terranueva is continuing its business plan and initiatives to market its cannabis products in order to secure short-term revenues. Transformation of Its Management Team On the eve of its first sales and marketing of cannabis, the Terranueva Board of Directors announces a new organizational structure. Dominique St-Louis joins as Vice President Finance and Chief Financial Officer for the entire organization. For the past 20 years, Mr. St-Louis has held various management positions within Groupe SAJY Inc., a group of private companies active in the communications sector, including the position of Chief Executive Officer at &CO Creative Collaborators, one of the largest independent creative agencies in Quebec. In this role, Dominique supports several local and national brands in developing in a very fast-changing environment. In parallel, from 2012 to 2015, he served as Chief Financial Officer for Perisson Oil Corporation (CSE: POG). Departure and Efficiency Within Management As a result of these organizational changes and the evolution of its strategic plan, Terranueva announces that Pierre Monet will resign from his position as an officer effective December 15, 2019. The Terranueva Board of Directors is grateful for Pierre Monet's contribution to the evolution of Terranueva since its creation. Mr. Monet leaves Terranueva with a solid foundation on which the team in place can build. ABOUT TERRANUEVA Terranueva relies on research and development and operational efficiency to become a key player in the emerging cannabis industry in Quebec. We aim to provide the Canadian and international markets with first-rate cannabis. Terranueva Pharma Corporation, its wholly owned subsidiary, holds the necessary licences from Health Canada to meet its mission. Operating in L'Assomption (Quebec), its mission is to produce cannabis with the highest standards in terms of efficiency, quality and stability. To achieve its goal, Terranueva Pharma is implementing a modular production approach, integrating the latest advances and innovations in process automation. Learn more about Terranueva at www.terranueva.ca. CSE nor its service providers (as defined in the policies) accept responsibility for the adequacy or accuracy of this press release.
Bullboard Posts